Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Colchicine”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,675 records · Page 93Linked to original sources

[Effect of tetanus toxin and colchicine on synaptic membranes of rat cerebral cortex].

It was shown that purified tetanus toxin did not influence the activity of the Na, K-ATP-ase fractions of the synaptic membranes of the rat cerebral cortex, it had no effect on the inhibition of Na, K,-ATP-ase under electrical stimulation of the synaptic membrane suspension, or the GABA--3H binding by the synaptosomes in vitro. Tetanus toxin (400--4000 DLM) and colchicine (1 mM) induced a decrease of osmotic sensitivity of the nerve endings. Colchicine in low concentrations (10(-5)-10(-3) M) failed to influence Mg-and Na, K-ATP-ases, but considerably inhibited both ATP-ases at higher concentrations.

Adenosine Triphosphatases↗

Accidental colchicine poisoning in a dog.

A 14-month-old toy poodle-cross was presented, after ingesting the owner's colchicine medication, with severe gastrointestinal disturbances and in shock. Despite aggressive medical management, the patient was euthanized approximately 24 hours after the ingestion. The clinical features, treatment, and necropsy findings of colchicine poisoning are discussed.

Animals↗

[Growth-inhibiting effect of colchicine on cultured vascular wall myocytes from arteriosclerotic lesions].

Proliferative, migratory, and secretory activities of vascular smooth muscle cells are currently discussed as determinants of human plaque and restenosis formation. Affecting these determinants with drugs may promise anti-arteriosclerotic effects. Plaque tissue was removed from both coronary and peripheral lesions of a total of 18 patients to cultivate smooth muscle cells (SMC) for subsequent in vitro studies. The antitubulin colchicine (C) caused a concentration-dependent decrease of SMC proliferative activity with an IC50 of 5 x 10(-9) M. Migratory activity was analyzed by a standardized semi-automatic video system. This parameter was reduced by C in a concentration-dependent manner (IC50: 5 x 10(-10) M). As shown by immunofluorescence microscopy, the typical structure of microtubules of C-treated SMCs was distorted, whereas the pattern of alpha-actin filaments remained unaltered. Transmission electron microscopy (TEM) revealed that the number of microtubules was diminished after addition of C, and that a distinct disorganization of cytoplasmic organelles as well as the formation of vacuoles had occurred. In vitro studies of human smooth muscle cells derived from vascular plaques indicate that colchicine may be useful as an anti-arteriosclerotic drug, since a concentration-dependent concordant effect on proliferation, migration, and secretory processes of the SMC could be demonstrated.

Aged↗

[Nephrogenic diabetes insipidus induced by colchicine--a case report].

In some cases diabetes insipidus may be induced by taking medications. In this article we report the case of a 58-year-old man with manifest polyuria induced by colchicine administered because of a gout attack. Interestingly, similar symptoms were observed 6 years earlier after treatment with gentamycin. In the described state of the examined patient early detection of the disease, colchicine withdrawal and temporary amiloride (and indometacin) administration led to a full normalisation of the patient's clinical status. A similar reaction to two different drugs responsible for only a small percentage of iatrogenic diabetes insipidus suggests that some patients may exhibit a general "hypersensitivity" to the development of a drug-induced vasopressin resistance and that patients with the history of iatrogenic diabetes insipidus should not be treated or should be treated cautiously with other drugs known to induce vasopressin-resistant polyuria.

Amiloride↗

Neutrophilic leukocyte inclusions in colchicine intoxication.

Large, darkly staining, intracytoplasmic inclusions were observed in the neutrophils of a young woman after suicidal ingestion of colchicine. The polymorphonuclear neutrophils also contained intracytoplasmic and intranuclear vacuoles. Electron microscopy enabled further characterization of these morphologic changes that, although nonspecific, are consistent with certain known toxic effects of colchicine.

Adolescent↗

[Amyloidosis in children with rheumatoid arthritis and the results of its long-term treatment with colchicine].

The authors provide materials of a clinical follow-up of 23 children suffering from rheumatoid arthritis (RA) with an outcome of amyloidosis of the internal organs, supported by morphological examination in 13 patients. 10 patients were treated with colchicine in a dose of 1-2 mg/day lasting from 6 months to 2 years and 7 months. The beneficial effect was attained in 7 children. In 3 patients with RA standing over 8 years, the results were negative. Colchicine merits attention as an effective drug for the treatment of secondary amyloidosis in RA patients.

Adolescent↗

The activity of alpha-amylase and gamma-amylase in serum and pancreatic homogenate of rats with experimental liver damage treated with colchicine.

In connection with extending the therapeutic application of colchicine to include its use in the treatment of liver fibrosis in cirrhosis and possible harmful effects of this drug on other organs, the pancreas in particular, the authors studied this problem experimentally. For this purpose a model of experimental cirrhosis in rats produced with chronic administration of carbon tetrachloride was used, and in the third and ninth months of the experiment the activity of alpha-amylase and gamma-amylase was determined in the serum and pancreatic homogenate. The results did not show any unfavourable effect of colchicine administered in their therapeutic doses for long time periods on the pancreas in experimental rats and in healthy controls.

Animals↗

[A case of Behçet disease with transverse sinus thrombosis and successful treatment with colchicine].

A 64-year-old man was admitted to our hospital because of headache and fever. Four months before admission, he had suffered from thrombophlebitis of the legs, erythema, oral aphtha and genital ulcers, and was diagnosed as having Behçet disease. Several days prior to admission he developed fever and was treated with enoxacine, which caused disorientation and abnormal behavior. These psychiatric symptoms disappeared after enoxacine was discontinued. On admission he was neurologically normal. Fever and headache disappeared spontaneously. However, he complained again of headache, and was suspected to have cerebral sinus thrombosis. Brain CT scan showed no abnormality, but brain MRI and cerebral angiography demonstrated right transverse sinus thrombosis and stasis. He was treated with colchicine, isosorbide, and ticlopidine. Because he had a gastric ulcer, corticosteroids were not indicated. Two months later, brain MRI demonstrated reduction of the size of the sinus thrombosis, and the clinical outcome was favorable. We would like to emphasize the usefulness of MRI and colchicine in the patient with Behçet disease complicated by sinus thromboses.

Behcet Syndrome↗

Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response.

One of the well-known consequences of established hypertension is an increase in connective tissue proteins in the walls of the large arterial blood vessels. Using renal clip and Dahl salt-sensitive rat models of systemic hypertension, we investigated the effect of developing hypertension on elastin production and accumulation in rat aorta. In both models of hypertension, increased accumulation of arterial elastin appeared coincidentally with, and was proportional to, elevation of blood pressure. In spite of large increases in absolute amounts of elastin, the proportion of elastin present in the vessel wall remained essentially constant from the earliest stage of the response. These changes in elastin synthesis and accumulation took place in the absence of evidence of cell proliferation. Treatment of Dahl rats with colchicine during development of hypertension affected blood pressure rise only marginally but abolished the vascular hypertrophic response. Our results suggest that the response of elastin production to increased blood pressure is rapid and sensitive, and that the stimulus for increased synthesis is an increase in wall stress. The striking effect of colchicine may indicate a role of elements of the cytoskeleton in the perception of stress by the vascular smooth muscle cells or in the transduction of that stress into increased production of connective tissue proteins.

Animals↗

[DNA distribution and mitotic index in Ehrlich ascites tumor after colchicine administration].

Additional information like the type of growth is efficient for the interpretation of single parameter DNA distribution curves of tumors. The consideration of mitotic indices leads to further insights. The different growth phases of the Ehrlich ascites tumor are characterized by reproducible DNA histograms. The mitotic index and the frequency of the four mitotic phases turn out to be independent of the growth phase. Colchicine exerts an obvious effect on the prophases and metaphases. In the histogram an accumulation of cells in the G2M phase is evident, also on a higher ploidy level. Nearly identical DNA histograms result in different growth phases. The mitotic index of prophases and metaphases is found to be nearly twice at the 11th and 15th day of growth in comparison with the 8th day. This indicates a higher sensitivity of the Ehrlich ascites tumor to colchicine in steady state which is not expressed in the histogram.

Animals↗

[Effect of alloxans on pancreatic B-cells with special regard to the alloxan-metal-complex theory. I. Effects of alloxan, alloxan-zinc chelates, dilauric acid and colchicine on blood sugar and rate of mitosis of B-cell Langerhans islets].

Alloxan, alloxan-zinc-chelate, sodium salt of dialuric acid, and colchicine significantly raised the blood sugar level under the previously mentioned experimental conditions 28 h after the application. The typical three-phase blood sugar curve development after alloxan (initial hyperglycemia, hypoglycemia, permanent hyperglycemia) was only approximately reached by dialuric acid which initiated, however, instead of the initial hyperglycemia a more pronounced hypoglycemic phase within the first 6 h. Alloxan-zinc-chelate protractedly and significantly made the blood sugar's increase up to the 7th d post injectionem, without being able to maintain a permanent hyperglycemia with half-normal dosage in comparison with alloxan. Non-diabetogenic alloxan doses (19 mg/kg i. v.) and the appropriate alloxan-zinc-chelate dosage (35 mg/kg) led to a significant increase of the blood sugar only in the chelate group with the long-term test up to 10 d, suggesting an increased and prolonged effect of the metal-chelates by stabilization of alloxan. The tested substances differently acted on the mitotic frequency of B-cells. The mitosis did not increase in the alloxan-zinc- and dialuric acid treated animals and was similar to normal animals far below the fractions of 1/10(6). A 4- and 5-fold increase of the mitotic frequency in the colchicine or alloxan treated animals as well as an accumulation of delayed metaphases suggest an impeded transition to the anaphase and include alloxan among the mitotic poisons.

Alloxan↗

Chemotaxis of human leucocytes: II. Effects of lectins, colchicine, cytochalasin B, cyclic nucleotides and immuno-stimulatory products.

Drugs or products acting as chemo-modulators were assayed for their effect on the chemotactic activity of human normal neutrophils by a method of direct microscopic observation. Lectins (PHA-P and Con A) have an inhibitory effect at the level of 10 micrograms/ml. Colchicine and Cytochalasin B have also an inhibitory effect at the level of 0.25.10(-6)M/ml and 0.20 micrograms/ml. For the cyclic nucleotides: dibutyryl cAMP and products such as norepinephrine, aminophylline that raise the cellular level of cAMP have an inhibitory effect, and whereas cGMP and carbamylcholine have a stimulatory effect Imidazole and levamisole, have some enhancement of chemotaxis but it is not significant. Lectins by binding to cell surface receptors which assume the recognition of a chemotactic gradient in the environment, colchicine and cytochalasin B by interfering with the cytoskeletal elements (microtubules and microfilaments) cyclic nucleotides involved in the metabolic activity during the cell motility. The data show that the integrity of one of these three sequences is necessary for the normal activity of chemotasxis. Animal and human models (i.e. mutant mouse bg/bg and Chediak-Higashi syndrome) give some clue of their interrelation.

Bucladesine↗

A selective histochemical method for the quantitative estimation of elastic fibers by computerized morphometric analysis. Effect of colchicin treatment.

A morphometric technique is reported that uses a new selective staining of the elastic system fibers in skin biopsy specimens to facilitate the quantitative evaluation of the volume fraction occupied by these elastic fibers in the tissue. The study of elastic fibers in the dermis of 30 patients, before and after six months of treatment with Colchicin, was carried out with a Quantimet 720 system. Preelastic (oxytalan and elaunin) fibers and mature elastic fibers were quantitated separately. Compared to the average volume fraction (surface occupied by the elastic fibers) before treatment with Colchicin (1.449 +/- 0.64%), the mean values after treatment were significantly increased (2.076 +/- 0.61%). The same results were found for the preelastic fibers: 0.807 +/- 0.51% before treatment and 1.025 +/- 0.54% after treatment. These results demonstrate the advantages of our monochromatic staining method for automatic quantitation of elastic fibers as well as the possibilities of the quantitative study of the elastic fibers in human dermis. This methodology should be applicable to other inherited or acquired diseases affecting skin elastic fibers as well as to other tissues containing elastic fibers.

Colchicine↗

[Mechanism of suppression of colchicine in experimental allergic encephalomyelitis].

Experimental allergic encephalomyelitis(EAE) has been used as an animal model of multiple sclerosis. The establishment of an adoptive transfer system employing encephalitogenic T-cells simplifies the analysis of the pathogenesis of this demyelinating disease. Colchicine, a drug used for gout, has recently been shown to be effective in the treatment of various autoimmune diseases including multiple sclerosis. Moreover, it has been shown that the drug suppresses the development of EAE in SJL mice in vivo. The precise mechanism of this suppression, however, remains unknown. Bearing this in mind, we have attempted to clarify this phenomenon using an adoptive transfer system with encephalitogenic T-cell lines. Lymphocytes from the SJL mice, which had been immunized with bovine myelin basic protein(MBP) and complete Freund's adjuvant were cultured for 4 days with MBP. Following this, the lymphocytes were subcultured in medium containing Con A supernatant(CAS) without antigen. The cells were then stimulated with MBP for 4 days in the presence of antigen presenting cells(APC). Cells were maintained by alternate antigenic stimulation without CAS and propagation in CAS medium over 90 days. The established cell lines were shown to have the cell surface markers of ly-1+, L3t4+, Ly-2-, which are characteristic of T helper/inducer cells. The syngeneic mice receiving these T-cells via tail veins developed neurological deficits in 2 weeks, and inflammatory demyelination was observed in the diseased animals, indicating that the T-cell lines did have encephalitogenicity. Colchicine treatment of the mixture of APC and T-cells in vitro suppressed the proliferation of T-cells, and this was dose dependent.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

[Changes induced by ouabain and colchicine in the transdentinal flow estimated in vivo by perfusion: the "push-pull" of the incisors of rats].

The active or passive mechanisms regulating the various movements of dentinal fluid have not yet been sufficiently studied. For this reason different "in vivo" factors that may modulate the kinetics of transdentinal flow were investigated. After systemic administration of a radiotracer in rats, the kinetics were examined with a push-pull perfusion device fixed to the incisor dentin. The drugs chosen, i.e. ouabain and colchicine, were for their respective effects on microtubules and on the ATPase-dependent Na+ K+ pump, since these two factors are involved in the transport process. Anesthetized animals were prepared to allow intravenous injection of iodine 125 (0,5 to 0,7 mCi), carotid sampling, and perfusion of upper incisors. Ouabain induced a very significant decrease in transdentinal flow, which was particularly evident in younger animals (2,81 x 10(-2) % vs 0,04 x 10(-2)%, p less than 0,05). However, colchicine produced two different kinds of results : at low doses (3,5 to 5 mg/100 g) the pulsatile pattern of the curves was partially inhibited, whereas, at higher doses (6 to 7 mg/100 g), the transdentinal flow of radioactivity increased. These results suggest that a combination of active and passive transport may be involved in the various movements of this fluid.

Animals↗

Treatment with 6-hydroxydopamine and colchicine decreases nerve growth factor levels in sympathetic ganglia and increases them in the corresponding target tissues.

A two-site enzyme immunoassay was used to determine the nerve growth factor (NGF) contents of sympathetic ganglia and their corresponding target tissues in adult rats. The destruction of sympathetic nerve terminals by 6-hydroxydopamine (6-OHDA) and the blockade of axonal transport by colchicine resulted in a rapid increase in the NGF levels of sympathetically innervated organs and a rapid decrease in the sympathetic ganglia. NGF levels in heart atrium, heart ventricle, submandibular gland, and iris increased 2- to 4-fold 12 hr after injection of 6-OHDA, whereas the NGF contents of stellate and superior cervical ganglia dropped to a minimal level of 3 to 4% of control 24 hr after injection. Twelve hours after treatment with colchicine the NGF levels in sympathetically innervated organs increased 2- to 3-fold, whereas the NGF contents of sympathetic ganglia fell to one-third of control values. The half-lives of NGF in the superior cervical and stellate sympathetic ganglia were 4.5 and 4.8 hr, respectively, as determined by the decrease of NGF content after treatment with 6-OHDA. These results indicate that the synthesis of NGF is normally confined to the innervated target organs with no significant contribution of ganglionic cells. This is consistent with the concept that NGF acts as a retrograde messenger between target organs and innervating sympathetic neurons.

Animals↗

[Characteristics of crossed resistance of neoplastic cells with high level of colchicine resistance].

Using a long-term selection the authors obtained the cells of a hamster with a rather high level of stability to colchicine (800-16,600 times). The nature of resistance of these cells to actinomycin differed from those having general origin with the newly obtained but having a lower level of stability to colchicine. This level of stability did not correlate with that to a selective agent.

Animals↗

Effect of colchicine and pilocarpine on the secretory activity of rat type II alveolar cells: an ultrastructural study.

Colchicine in a total dose of 0.6 mg/100 g body weight per day was shown to reduce the level of apical surfactant secretion by type II alveolar cells in random-bred male albino rats, thereby demonstrating that the cytoplasmic microtubules participate in the release of surfactant into the alveolar lumen. In addition, basal secretion of surface-active material was found in 51% of all the cells. In a single dose of 8 mg/100 g b.w., pilocarpine stimulated apical surfactant secretion. If injected after colchicine, it slightly increased the number of type II alveolar cells ready to release surfactant, but actual secretion was not observed; the level of basal secretion did not increase. It has been suggested that microtubular function is not completely responsible for basal secretion and is only partly responsible for apical surfactant secretion.

Animals↗